3 completed, 2 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow F2G Biotech GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olorofim in Early Coccidioidal Meningitis olorofim - Coccidioidal Meningitis | Phase 2 | Recruiting | Fariba Donovan | 12 | 2026-06-01 | 2026-07-27 |
| A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment Olorofim - Renal Impairment | Phase 1 | Completed | F2G Biotech GmbH | 16 | 2022-02-10 | 2023-01-20 |
| A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment Olorofim - Hepatic Impairment | Phase 1 | Completed | F2G Biotech GmbH | 32 | 2021-07-02 | 2022-03-16 |
| Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options Olorofim - Invasive Fungal Infections | Phase 2 | Completed | F2G Biotech GmbH | 203 | 2018-06-06 | 2024-07-10 |
| FungiScope - A Global Emerging Fungal Infection Registry Invasive Fungal Disease | Recruiting | University of Cologne | 1000 | 2003-03-01 | 2023-12-05 |
Coccidioidomycosis (2) · Invasive Fungal Infections (2) · Coccidioidal Meningitis (1) · Renal Insufficiency (1)
olorofim (4)
United States (4) · Germany (2) · Australia (1) · Belgium (1) · Brazil (1) · Egypt (1) · France (1) · Israel (1) · Netherlands (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Thailand (1) · Turkey (Türkiye) (1)
Fariba Donovan, MD, PhD (1) · Oliver A. Cornely, Professor (1) · Sharon Chen (1)
PMID 26969258, PMID 27846057, PMID 35144992, PMID 40541222, PMID 41914555, PMID 42008658, PMID 42475691, PMID 42774582